A long-standing question has been how viral RNAs that use genetic codes different from those used in human cells can still drive efficient viral protein production during infection. It emerges that ...
Refeyn, developer of pioneering mass photometry technology, expands its global adoption across contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results